首页> 外文期刊>Retrovirology >Vaccination with live attenuated simian immunodeficiency virus causes dynamic changes in intestinal CD4+CCR5+ T cells
【24h】

Vaccination with live attenuated simian immunodeficiency virus causes dynamic changes in intestinal CD4+CCR5+ T cells

机译:用减毒的猿猴免疫缺陷病毒进行活疫苗接种会导致肠道CD4 + CCR5 + T细胞动态变化

获取原文

摘要

Background Vaccination with live attenuated SIV can protect against detectable infection with wild-type virus. We have investigated whether target cell depletion contributes to the protection observed. Following vaccination with live attenuated SIV the frequency of intestinal CD4+CCR5+ T cells, an early target of wild-type SIV infection and destruction, was determined at days 3, 7, 10, 21 and 125 post inoculation. Results In naive controls, modest frequencies of intestinal CD4+CCR5+ T cells were predominantly found within the LPL TTrM-1 and IEL TTrM-2 subsets. At day 3, LPL and IEL CD4+CCR5+ TEM cells were dramatically increased whilst less differentiated subsets were greatly reduced, consistent with activation-induced maturation. CCR5 expression remained high at day 7, although there was a shift in subset balance from CD4+CCR5+ TEM to less differentiated TTrM-2 cells. This increase in intestinal CD4+CCR5+ T cells preceded the peak of SIV RNA plasma loads measured at day 10. Greater than 65.9% depletion of intestinal CD4+CCR5+ T cells followed at day 10, but overall CD4+ T cell homeostasis was maintained by increased CD4+CCR5- T cells. At days 21 and 125, high numbers of intestinal CD4+CCR5- naive TN cells were detected concurrent with greatly increased CD4+CCR5+ LPL TTrM-2 and IEL TEM cells at day 125, yet SIV RNA plasma loads remained low. Conclusions This increase in intestinal CD4+CCR5+ T cells, following vaccination with live attenuated SIV, does not correlate with target cell depletion as a mechanism of protection. Instead, increased intestinal CD4+CCR5+ T cells may correlate with or contribute to the protection conferred by vaccination with live attenuated SIV.
机译:背景减毒活SIV疫苗可以预防野生型病毒的可检测感染。我们已经研究了靶细胞消耗是否有助于观察到的保护。用减毒活疫苗接种后,在接种后第3、7、10、21和125天确定了肠道CD4 + CCR5 + T细胞(野生型SIV感染和破坏的早期目标)的频率。结果在幼稚对照组中,主要在LPL TTrM-1和IEL TTrM-2子集中发现了适度的肠道CD4 + CCR5 + T细胞频率。在第3天,LPL和IEL CD4 + CCR5 + TEM细胞显着增加,而分化程度较低的亚群则大大减少,这与激活诱导的成熟一致。在第7天,CCR5表达保持高水平,尽管亚群平衡从CD4 + CCR5 + TEM转移至分化程度较低的TTrM-2细胞。在第10天,肠道CD4 + CCR5 + T细胞的这种增加先于SIV RNA血浆负荷的峰值。在第10天,肠道CD4 + CCR5 + T细胞的消耗大于65.9%,但通过增加CD4可以维持总体CD4 + T细胞稳态。 + CCR5-T细胞。在第21天和第125天,在第125天检测到大量肠道CD4 + CCR5-幼稚TN细胞,同时CD4 + CCR5 + LPL TTrM-2和IEL TEM细胞大大增加,但SIV RNA血浆负荷仍然很低。结论接种减毒活SIV疫苗后,肠道CD4 + CCR5 + T细胞的增加与保护靶细胞不相关。取而代之的是,肠道CD4 + CCR5 + T细胞增加可能与减毒活SIV疫苗接种所赋予的保护作用相关或有所贡献。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号